Notably, FAw3byFA increased effector memory CD4+ T cells, implicated in tumor progression (51), with mediation analysis attributing ~10% of CRC risk to this pathway—potentially via T-cell exhaustion (51). The gene discussed is CD4; the disease is neoplasm.